Skip to main content

Table 3 Comparison of tumor clinical characters between ESBL and non-ESBL among 358 UTI episodes

From: Extended-spectrum beta-lactamase-producing Enterobacteriaceae related urinary tract infection in adult cancer patients: a multicenter retrospective study, 2015–2019

Tumor information

Total, n

ESBL n (%)

Non-ESBL n (%)

P-value

Tumor types

358

160 (44.7)

198 (55.3)

0.001

Urological cancer

64

40 (62.5)

24 (37.5)

0.002

 Prostate cancer

18

14 (77.8)

4 (22.2)

 

 Bladder cancer

31

20 (64.5)

11 (35.5)

 

 Ureter and renal pelvis cancer

4

2 (50.0)

2 (50.0)

 

 Penile cancer

2

1 (50.0)

1 (50.0)

 

 Renal cancer

9

3 (33.3)

6 (66.7)

 

Gynecological cancer

73

37 (50.7)

36 (49.3)

0.248

 Cervical caner

54

29 (53.7)

25 (46.3)

 

 Ovarian and ureter cancer

14

7 (50.0)

7 (50.0)

 

 Endometrial cancer

5

1 (20.0)

4 (80.0)

 

Gastrointestinal neoplasms

85

38 (44.7)

47 (55.3)

0.998

 Rectal cancer

33

18 (54.5)

15 (45.5)

 

 Colorectal cancer

19

9 (47.4)

10 (52.6)

 

 Esophagus cancer

9

3 (33.3)

6 (66.7)

 

 Stomach cancer

9

3 (33.3)

6 (66.7)

 

 Liver cancer

6

2 (33.3)

4 (66.7)

 

 Pancreatic cancer

6

2 (33.3)

4 (66.7)

 

 Gallbladder cancer

3

1 (33.3)

2 (66.7)

 

Hematologic malignancy

24

8 (33.3)

16 (66.7)

0.247

 Lymphoma

24

8 (33.3)

16 (66.7)

 

Thoracic neoplasms

89

25 (28.1)

64 (71.9)

 < 0.001

 Breast cancer

19

7 (36.8)

12 (63.2)

 

 Lung cancer

70

18 (25.7)

52 (74.3)

 

 Other

23

12 (52.2)

11 (47.8)

0.456

Pathological type

358

160

198

0.137

 Adenomatous carcinoma

175

71 (40.6)

104 (59.4)

 

 Squamous cell carcinoma

74

40 (54.1)

34 (45.9)

 

 Neuroendocrine carcinoma

31

11 (35.5)

20 (64.5)

 

 Urothelial carcinoma

31

19 (61.3)

12 (38.7)

 

 Non-Hodgkin lymphoma

24

8 (33.3)

16 (66.7)

 

 Sarcoma

8

4 (50.0)

4 (50.0)

 

Other

15

7 (46.7)

8 (53.3)

 

Clinical stages

358

160

198

0.028

 I

24

10 (41.7)

14 (58.3)

 

 II

32

11 (34.4)

21 (65.6)

 

 III

79

26 (32.9)

53 (67.1)

 

 IV

223

113 (50.7)

110 (49.3)